Asciminib
Back to search| Scientific Name: | Asciminib |
| Brand Name: | Scemblix |
| Company Owner: | Not Available |
| Mechanism Of Action | In most patients with chronic myeloid leukemia (CML) , |
| Description of the Drug: | Asciminib is an inhibitor of ABL/BCR-ABL1 tyrosine kinase for the treatment of patients with Philadelphia chromosome-positive CML, including those with the T315I mutation. |
| Protein Data Bank: |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB12597
